Editors:
- Provides an analysis of two "hot topics" in the field of antitrust and unfair competition law
- Identifies general trends and highlights differences and the most interesting features of national regulations in the relevant fields
- Written by prominent and respected practitioners in the field
- Covers a broad range of jurisdictions
Part of the book series: LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition (LIDC)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (26 chapters)
-
Front Matter
-
Antitrust in Pharmaceutical Markets
-
Front Matter
-
-
Geographical Rules of Origin
-
Front Matter
-
About this book
This book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property.
The first part discusses the application of competition law in the pharmaceutical sector, which continues to be a focus for anti-trust authorities around the world. A detailed international report explores the extent to which the application of the competition rules in the pharmaceutical sector should be affected by the specific characteristics of those products and markets (including consumer protection rules, the need to promote innovation, the need to protect public budgets, and other public interest considerations). It provides an excellent comparative study of this complex subject, which lies at the interface between competition law and intellectual property law.
The second part of the book gathers contributions from various jurisdictions on the topic of “What rules should govern claims by suppliers about the national or geographic origin of their goods or services?” This section presents an international report, which offers an unparalleled comparative analysis of this topic, bringing together common themes and contrasting the various national provisions dealing with indications of origin, amongst other things.
The book also includes the resolutions passed by the General Assembly of the International League of Competition Law (LIDC) following a debate on each of these topics, which include proposed solutions and recommendations. The LIDC is a long-standing international association that focuses on the interface between competition law and intellectual property law, including unfair competition issues.
Editors and Affiliations
-
Kobel Avocat Attorney-at-law, Geneva, Switzerland
Pierre Kobel
-
Këllezi Legal, Geneva, Switzerland
Pranvera Këllezi
-
Addleshaw Goddard LLP, London, United Kingdom
Bruce Kilpatrick
Bibliographic Information
Book Title: Antitrust in Pharmaceutical Markets & Geographical Rules of Origin
Editors: Pierre Kobel, Pranvera Këllezi, Bruce Kilpatrick
Series Title: LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition
DOI: https://doi.org/10.1007/978-3-319-55813-4
Publisher: Springer Cham
eBook Packages: Law and Criminology, Law and Criminology (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2017
Hardcover ISBN: 978-3-319-55812-7Published: 28 September 2017
Softcover ISBN: 978-3-319-85755-8Published: 17 May 2018
eBook ISBN: 978-3-319-55813-4Published: 20 September 2017
Series ISSN: 2199-742X
Series E-ISSN: 2199-7438
Edition Number: 1
Number of Pages: XV, 497
Number of Illustrations: 1 b/w illustrations, 3 illustrations in colour
Topics: IT Law, Media Law, Intellectual Property, Pharmacology/Toxicology, International Economic Law, Trade Law, Private International Law, International & Foreign Law, Comparative Law , Medical Law, Business Law